As of December 2024, General Biologicals Corporation has a market cap of $30.92M. This makes General Biologicals Corporation the world's 25692th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $42.26M | -12.83% |
2023 | $48.48M | -2.21% |
2022 | $49.58M | -22.57% |
2021 | $64.04M | -34.94% |
2020 | $98.43M | 371.10% |
2019 | $20.89M | -5.70% |
2018 | $22.16M | -20.33% |
2017 | $27.81M | -25.31% |
2016 | $37.23M | -35.40% |
2015 | $57.63M | 16.32% |
2014 | $49.54M | -15.90% |
2013 | $58.91M | 233.24% |
2012 | $17.68M | 67.44% |
2011 | $10.56M | 0.00% |
2010 | $10.56M | 0.00% |
2009 | $10.56M | 0.00% |
2008 | $10.56M | -21.34% |
2007 | $13.42M | - |